AI Drug Discovery and Design Global Market Insights 2021

The “AI Drug Discovery and Design Global Market Insights 2021, Analysis and Forecast to 2026, by Market Participants, Regions, Technology, Application” rp;'[-0/=eport has been added to’s offering.

This report describes the global market size of AI Drug Discovery and Design from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.

For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA

The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of AI Drug Discovery and Design as well as some small players.

Companies Covered:

  • Relay Therapeutics
  • AbCellera
  • Schrodinger
  • Recursion Pharmaceuticals
  • PathAI
  • Insitro
  • Valo Health
  • Cellarity
  • XtalPi
  • BenevolentAI
  • Datavant
  • Atomwise
  • Exscientia Ltd

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • Precision Target
  • Precision Design
  • Precision Experiment
  • Precision Medicine

Base Year: 2021

Historical Data: from 2016 to 2020

Forecast Data: from 2021 to 2026

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to

Related posts

Applied Digital and ZEDEDA form a Strategic Partnership

Globe Newswire

Top Independent Research Firm Recognizes Tiger Analytics as a Leader in Specialized Insights Services

PR Newswire

Tredence Recognized in Now Tech: TPM Q4 2021

PR Newswire